Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.9K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Steven T. Harris · JAMA · 1999 · 2.5K citations

Medicine, Endocrinology, Bone Augmentation +16

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Jean‐Yves Reginster, H. W. Minne, O. H. Sørensen et al. · Osteoporosis International · 2000 · 1.6K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

Charles H. Chesnut, Arne Skag, Claus Christiansen et al. · Journal of Bone and Mineral Research · 2004 · 1.2K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims Databases

Ethel S. Siris, Steven T. Harris, Clifford J. Rosen et al. · Mayo Clinic Proceedings · 2006 · 709 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17